New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0194701

PubMed Identifier: 29558515

Publication URI: http://europepmc.org/abstract/MED/29558515

Type: Journal Article/Review

Volume: 13

Parent Publication: PloS one

Issue: 3

ISSN: 1932-6203